There has been an increasing interest in remdesivir research within the scientific medical community because of the emerging evidence suggesting its beneficial role in patients with Covid‑19. Remdesivir which can be given intravenously and not orally has an anti-viral against several RNA viruses. The aim of this paper is to review remdesivir research progress.